- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.35 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.2: 4 residues within 4Å:- Chain A: T.190, L.227, N.230, Y.234
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.230
- Water bridges: A:N.230
NAG.3: 1 residues within 4Å:- Chain A: N.211
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.211
NAG.4: 6 residues within 4Å:- Chain A: G.237, K.238, R.239, N.241, L.246, W.248
No protein-ligand interaction detected (PLIP)NAG.5: 1 residues within 4Å:- Chain A: N.201
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.201
NAG.10: 4 residues within 4Å:- Chain C: T.190, L.227, N.230, Y.234
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:N.230
- Water bridges: C:N.230
NAG.11: 1 residues within 4Å:- Chain C: N.211
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.211
NAG.12: 6 residues within 4Å:- Chain C: G.237, K.238, R.239, N.241, L.246, W.248
No protein-ligand interaction detected (PLIP)NAG.13: 1 residues within 4Å:- Chain C: N.201
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.201
NAG.18: 4 residues within 4Å:- Chain E: T.190, L.227, N.230, Y.234
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:N.230
- Water bridges: E:N.230
NAG.19: 1 residues within 4Å:- Chain E: N.211
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:N.211
NAG.20: 6 residues within 4Å:- Chain E: G.237, K.238, R.239, N.241, L.246, W.248
No protein-ligand interaction detected (PLIP)NAG.21: 1 residues within 4Å:- Chain E: N.201
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:N.201
- 3 x YOD: (1R,3S,5S,7S)-N-[(1r,4R)-4-aminocyclohexyl]-3-[(methylsulfanyl)methyl]-5-phenyladamantane-1-carboxamide(Non-covalent)
YOD.6: 10 residues within 4Å:- Chain A: R.37, V.39, G.40, A.74, G.75, L.159
- Chain B: L.14, Y.16, T.19, M.47
10 PLIP interactions:5 interactions with chain B, 5 interactions with chain A- Hydrophobic interactions: B:L.14, B:Y.16, B:Y.16, B:Y.16, B:Y.16, A:V.39, A:V.39, A:L.159, A:L.159
- Hydrogen bonds: A:R.37
YOD.14: 10 residues within 4Å:- Chain C: R.37, V.39, G.40, A.74, G.75, L.159
- Chain D: L.14, Y.16, T.19, M.47
10 PLIP interactions:5 interactions with chain D, 5 interactions with chain C- Hydrophobic interactions: D:L.14, D:Y.16, D:Y.16, D:Y.16, D:Y.16, C:V.39, C:V.39, C:L.159, C:L.159
- Hydrogen bonds: C:R.37
YOD.22: 10 residues within 4Å:- Chain E: R.37, V.39, G.40, A.74, G.75, L.159
- Chain F: L.14, Y.16, T.19, M.47
10 PLIP interactions:5 interactions with chain E, 5 interactions with chain F- Hydrophobic interactions: E:V.39, E:V.39, E:L.159, E:L.159, F:L.14, F:Y.16, F:Y.16, F:Y.16, F:Y.16
- Hydrogen bonds: E:R.37
- 6 x GOL: GLYCEROL(Non-functional Binders)
GOL.7: 6 residues within 4Å:- Chain A: E.93, C.94, L.95, P.96, D.123, R.145
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:D.123, A:D.123, A:R.145
- Water bridges: A:A.97
GOL.8: 6 residues within 4Å:- Chain B: N.62, E.63, T.65, Q.66
- Chain F: W.30
- Ligands: NAG-NAG-BMA-MAN-MAN.1
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:N.62, B:E.63, B:T.65, B:Q.66
GOL.15: 6 residues within 4Å:- Chain C: E.93, C.94, L.95, P.96, D.123, R.145
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:D.123, C:D.123, C:R.145
- Water bridges: C:A.97
GOL.16: 6 residues within 4Å:- Chain B: W.30
- Chain D: N.62, E.63, T.65, Q.66
- Ligands: NAG-NAG-BMA-MAN-MAN.9
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:N.62, D:E.63, D:T.65, D:Q.66
GOL.23: 6 residues within 4Å:- Chain E: E.93, C.94, L.95, P.96, D.123, R.145
4 PLIP interactions:4 interactions with chain E- Hydrogen bonds: E:D.123, E:D.123, E:R.145
- Water bridges: E:A.97
GOL.24: 6 residues within 4Å:- Chain D: W.30
- Chain F: N.62, E.63, T.65, Q.66
- Ligands: NAG-NAG-BMA-MAN-MAN.17
4 PLIP interactions:4 interactions with chain F- Hydrogen bonds: F:N.62, F:E.63, F:T.65, F:Q.66
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Abendroth, J. et al., Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075146. to be published
- Release Date
- 2021-11-24
- Peptides
- GP1: ACE
GP2: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.35 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x YOD: (1R,3S,5S,7S)-N-[(1r,4R)-4-aminocyclohexyl]-3-[(methylsulfanyl)methyl]-5-phenyladamantane-1-carboxamide(Non-covalent)
- 6 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Abendroth, J. et al., Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075146. to be published
- Release Date
- 2021-11-24
- Peptides
- GP1: ACE
GP2: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B